Resources

Respiratory syncytial virus (RSV) is a major, under–recognized public health problem causing more severe respiratory infections and hospitalizations in infants and young children each year than any other pathogen. New immunization tools now recommended for global use by the World Health Organization (WHO) could help change that.The opportunity to address this pervasive virus has never been better. To raise awareness, WHO and PATH have developed a toolkit of communication materials that public health stakeholders and advocates can use to share information about RSV disease, new prevention tools, and delivery considerations. Other expert contributors include the US Centers for Disease Control and Prevention, Seattle Children's Hospital/University of Washington, UMC Utrecht, the International Vaccine Access Center (IVAC), RRD Design, and more.To accommodate varying audience and engagement needs, this toolkit includes a stand-alone RSV primer presentation (and fact sheet) providing an overview of RSV disease and prevention options. Also available are modular PowerPoint slides that can be mixed and matched with the primer presentation to dive deeper into key topics for informing understanding and decision-making around RSV prevention. All slides come with speaker notes.Additional social media tools make sharing information about RSV with your network easy!To learn more about the toolkit, visit the web page.NOTE: Files available here as read-only. Editable files are readily available upon request. Please contact us.

The Rotary Healthy Communities Challenge (RHCC) project is supporting community health workers (CHWs) in Nigeria, the Democratic Republic of the Congo, Zambia, and Mozambique to implement integrated community case management in their communities. Integrated community case management is a globally recognized strategy to equip CHWs with the training and tools to diagnose, treat, and refer cases of malaria, pneumonia, and diarrhea.In the flow charts below, learn about the selection, training, and deployment process for CHWs in each country to implement integrated community case management.

This is a simple, Excel-based tool for assessing and comparing costs of human papillomavirus (HPV) vaccination programs with each HPV vaccine product available in the global market. It aims to help national-level policymakers specifically in middle-income countries compare products and estimate vaccination program costs for different HPV vaccines, exploring up to four different vaccine options at a time. The tool calculates cold chain volume and costs annually and for a total period of five years. Cost estimates are composed of vaccine cost (i.e., vaccine and supplies procurement and international shipping) and vaccination program costs (i.e., vaccine cost and cost of delivery).It is important to note that cost is only one consideration when selecting an HPV vaccine product, and users involved in decision-making around new vaccine introduction/switch or product selection should always consider other dimensions as well. This model is meant to provide insights into the potential costs of alternative product choices and should not replace detailed budget planning once a product has been selected.A user guide is included in the file on a tab labeled “READ ME FIRST” which provides detailed instructions on how to use the tool and interpret the results. The tool is available to download in multiple languages. Please be sure to check out this six-minute tutorial video, which is in English, with French and Spanish subtitled versions also available. If you have additional questions or need support, contact PATH’s Health Economics & Outcomes Research team: HEOR@path.org.NOTE: Please refer to this web page for the most up-to-date version of the calculator, which is periodically updated to reflect the evolving vaccine landscape.

This fact sheet describes PATH's technical assistance work with low- and middle-income vaccine manufacturers and the Sustaining Vaccine Manufacturing program. It provides an overview of how we work and what we do, our capabilities, our successes, and how to work with us.

This fact sheet details successes from PATH's Sustaining Vaccine Manufacturing program to improve global access to essential, high-quality, affordable vaccines. Highlighted examples include navigating and achieving WHO prequalification; keeping up with rising regulatory standards; developing fit-for-purpose vaccine technologies; finding solutions for critical supply issues; conducting landscape and capacity assessments; fostering collaboration across borders; and more.